Transfection News and Research

RSS
SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

SARS-CoV-2 mRNA vaccines do not stimulate interferon stimulatory gene expression in Aicardi Goutières Syndrome patients

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

Study reports SARS-CoV-2 accessory proteins downregulate MHC-I expression using distinct mechanisms

Downregulation of MHC-I surface expression by SARS-CoV-2 accessory proteins

Downregulation of MHC-I surface expression by SARS-CoV-2 accessory proteins

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

Investigating the role of cyclins and cyclin-dependent kinases in host restriction of SARS-CoV-2 infection

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

SARS-CoV-2 variants are not evolving to escape from T cell-mediated immunity

Proximity labeling to identify high-confidence SARS-CoV-2 interactors

Proximity labeling to identify high-confidence SARS-CoV-2 interactors

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

Multivalent messenger ribonucleic acid-lipid nanoparticle vaccines against SARS-CoV-2

Artificial circular RNAs found to bypass cellular antiviral responses

Artificial circular RNAs found to bypass cellular antiviral responses

CRISPR/Cas9 deletions induce adverse on-target genomic effects

CRISPR/Cas9 deletions induce adverse on-target genomic effects

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Scientists explore impact of SARS-CoV-2 natural immunity on vaccine-induced immunity

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

Study shows that the SARS-CoV-2 envelope protein potently restricts HIV-1 infection

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

ProteoGenix launches new XtenCHOTM Transient CHO Expression System to improve biologics development

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study investigates room-temperature stable, self-amplifying RNA vaccine against SARS-CoV-2

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Study identified multiple siRNAs spanning the SARS-CoV-2 genome with potent antiviral activity

Importance of Numb-associated kinases in SARS-CoV-2 infection

Importance of Numb-associated kinases in SARS-CoV-2 infection

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

Bioactive small molecules enhance CRISPR/Cas9 loss-of-function editing in human cells

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron